Altimmune EV to Revenues Insights | YCharts

Altimmune Inc (ALT)

4.765 +0.02 (+0.42%) USD | NASDAQ | Apr 02, 16:00

4.65 -0.12 (-2.41%) After-Hours: 20:00

Quote

View 4,000+ Financial Data Types:

Add

Browse

EV to Revenues Chart

View EV to Revenues for ALT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EV to Revenues Chart

Start Trial

Historical Data

View Historical Data

Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks

Start Trial

Viking Therapeutics Inc	--
Eli Lilly and Co	Upgrade
Amgen Inc	Upgrade
Terns Pharmaceuticals Inc	--
Pfizer Inc	Upgrade

EV to Revenues Related Metrics

EV to CFO	Upgrade
EV to Free Cash Flow	Upgrade
EV to Assets (Quarterly)	Upgrade
EV to Earnings	Upgrade